Alpha 2.0
Login Register
» Authors » Hugues Charest

Hugues Charest

Explore the profile of Hugues Charest including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 78
Citations 2463
Followers 0
Related Specialties
Infectious Diseases
Microbiology
General Medicine
Top 10 Co-Authors
Gaston De Serres
Danuta M Skowronski
James A Dickinson
Yan Li
Nathalie Bastien
Mel Krajden
Suzana Sabaiduc
Jonathan B Gubbay
Anne-Luise Winter
Steven J Drews
Published In
J Infect Dis
Euro Surveill
Clin Infect Dis
PLoS One
J Clin Microbiol
Affiliations
Soon will be listed here.
Recent Articles
1.
The Changing Landscape of Respiratory Viruses Contributing to Hospitalizations in Quebec, Canada: Results From an Active Hospital-Based Surveillance Study
Gilca R, Amini R, Carazo S, Doggui R, Frenette C, Boivin G, et al.
JMIR Public Health Surveill . 2024 May; 10():e40792. PMID: 38709551
Background: A comprehensive description of the combined effect of SARS-CoV-2 and respiratory viruses other than SARS-CoV-2 (ORVs) on acute respiratory infection (ARI) hospitalizations is lacking. Objective: This study aimed to...
2.
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)
Skowronski D, Zhan Y, Kaweski S, Sabaiduc S, Khalid A, Olsha R, et al.
Euro Surveill . 2024 Feb; 29(7). PMID: 38362622
The Canadian Sentinel Practitioner Surveillance Network reports mid-season 2023/24 influenza vaccine effectiveness (VE) of 63% (95% CI: 51-72) against influenza A(H1N1)pdm09, lower for clade 5a.2a.1 (56%; 95% CI: 33-71) than...
3.
Influenza Hospitalization Burden by Subtype, Age, Comorbidity, and Vaccination Status: 2012-2013 to 2018-2019 Seasons, Quebec, Canada
Carazo S, Guay C, Skowronski D, Amini R, Charest H, De Serres G, et al.
Clin Infect Dis . 2023 Oct; 78(3):765-774. PMID: 37819010
Background: Influenza immunization programs aim to reduce the risk and burden of severe outcomes. To inform optimal program strategies, we monitored influenza hospitalizations over 7 seasons, stratified by age, comorbidity,...
4.
Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk
Brousseau N, Carazo S, Febriani Y, Padet L, Hegg-Deloye S, Cadieux G, et al.
Clin Infect Dis . 2023 Sep; 78(2):461-469. PMID: 37769158
Introduction: During the 2022 mpox outbreak, the province of Quebec, Canada, prioritized first doses for pre-exposure vaccination of people at high mpox risk, delaying second doses due to limited supply....
5.
Timing and Predictors of Loss of Infectivity Among Healthcare Workers With Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study
Dzieciolowska S, Charest H, Roy T, Fafard J, Carazo S, Levade I, et al.
Clin Infect Dis . 2023 Sep; 78(3):613-624. PMID: 37675577
Background: There is a need to understand the duration of infectivity of primary and recurrent coronavirus disease 2019 (COVID-19) and identify predictors of loss of infectivity. Methods: Prospective observational cohort...
6.
Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23
Skowronski D, Chuang E, Sabaiduc S, Kaweski S, Kim S, Dickinson J, et al.
Euro Surveill . 2023 Feb; 28(5). PMID: 36729117
The Canadian Sentinel Practitioner Surveillance Network estimated vaccine effectiveness (VE) during the unusually early 2022/23 influenza A(H3N2) epidemic. Like vaccine, circulating viruses were clade 3C.2a1b.2a.2, but with genetic diversity affecting...
7.
Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak
Harrison L, Bergeron G, Cadieux G, Charest H, Fafard J, Levade I, et al.
Ann Intern Med . 2022 Dec; 176(1):67-76. PMID: 36508736
Background: Monkeypox, a viral zoonotic disease, is causing a global outbreak outside of endemic areas. Objective: To characterize the outbreak of monkeypox in Montréal, the first large outbreak in North...
8.
Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada
Kim S, Chuang E, Sabaiduc S, Olsha R, Kaweski S, Zelyas N, et al.
Euro Surveill . 2022 Sep; 27(38). PMID: 36148674
Influenza virus circulation virtually ceased in Canada during the COVID-19 pandemic, re-emerging with the relaxation of restrictions in spring 2022. Using a test-negative design, the Canadian Sentinel Practitioner Surveillance Network...
9.
Detection and Sequencing of Multiple Human Norovirus Genotypes from Imported Frozen Raspberries Linked to Outbreaks in the Province of Quebec, Canada, in 2017
Raymond P, Paul S, Perron A, Bellehumeur C, Larocque E, Charest H
Food Environ Virol . 2022 Jan; 14(1):40-58. PMID: 35066807
Human noroviruses are among the main causes of acute gastroenteritis worldwide. Frozen raspberries have been linked to several norovirus food-related outbreaks. However, the extraction of norovirus RNA from frozen raspberries...
10.
SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells
Ding S, Adam D, Beaudoin-Bussieres G, Tauzin A, Gong S, Gasser R, et al.
Viruses . 2022 Jan; 14(1). PMID: 35062211
Different serological assays were rapidly generated to study humoral responses against the SARS-CoV-2 Spike glycoprotein. Due to the intrinsic difficulty of working with SARS-CoV-2 authentic virus, most serological assays use...